Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach... Show more
CRON's Aroon Indicator triggered a bullish signal on August 01, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 132 similar instances where the Aroon Indicator showed a similar pattern. In of the 132 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on August 28, 2025. You may want to consider a long position or call options on CRON as a result. In of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
CRON moved above its 50-day moving average on August 04, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRON advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for CRON moved out of overbought territory on August 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where CRON's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CRON turned negative on August 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CRON broke above its upper Bollinger Band on August 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.920) is normal, around the industry mean (16.678). P/E Ratio (52.000) is within average values for comparable stocks, (74.024). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.914). CRON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (7.645) is also within normal values, averaging (42.522).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
pharmaceutical, medical marijuana, cannabis
Industry PharmaceuticalsGeneric
A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.
Ticker / NAME | Correlation To CRON | 1D Price Change % | ||
---|---|---|---|---|
CRON | 100% | N/A | ||
SNDL - CRON | 73% Closely correlated | -0.37% | ||
TLRY - CRON | 60% Loosely correlated | -6.12% | ||
OGI - CRON | 59% Loosely correlated | N/A | ||
CGC - CRON | 57% Loosely correlated | -4.26% | ||
ACB - CRON | 55% Loosely correlated | -3.56% | ||
More |
Ticker / NAME | Correlation To CRON | 1D Price Change % |
---|---|---|
CRON | 100% | N/A |
Pharmaceuticals: Generic industry (223 stocks) | 18% Poorly correlated | -0.13% |